-
Location
-
295 Madison Avenue, 32 Nd Fl, New York, NY
-
Summary
-
The estimated value of insider holdings of Acorn Bioventures, L.P. is at least $9.1M dollars as of May 19, 2025. Acorn Bioventures, L.P. is the 10%+ Owner of OnKure Therapeutics, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $9.1M.
-
Signature
-
ACORN BIOVENTURES, L.P., By: Acorn Capital Advisors GP, LLC, its general partner, By: /s/ Anders Hove, Manager